Millennium Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.7M	Buy	4,022,909 +1,940,729	+93%	+$24.5M	0.03%	904
2025 Q4	$34.5M	Sell	2,082,180 -2,999,271	-59%	-$42.8M	0.02%	1070
2025 Q3	$59.8M	Buy	5,081,451 +2,830,954	+126%	+$29.2M	0.05%	743
2025 Q2	$21.6M	Buy	2,250,497 +1,727,134	+330%	+$9.56M	0.02%	1504
2025 Q1	$3.28M	Buy	523,363 +463,372	+772%	+$2.81M	﹤0.01%	3296
2024 Q4	$487K	Buy	59,991 +27,063	+82%	+$335K	﹤0.01%	4772
2024 Q3	$595K	Buy	+32,928	New	+$460K	﹤0.01%	4692
2024 Q2	–	Sell	-225,024	Closed	-$2.39M	–	6484
2024 Q1	$2.39M	Buy	225,024 +54,980	+32%	+$467K	﹤0.01%	3572
2023 Q4	$1.55M	Buy	170,044 +30,696	+22%	+$264K	﹤0.01%	3809
2023 Q3	$1.45M	Buy	139,348 +111,407	+399%	+$1.53M	﹤0.01%	3881
2023 Q2	$400K	Sell	27,941 -29,922	-52%	-$345K	﹤0.01%	4697
2023 Q1	$413K	Buy	+57,863	New	+$508K	﹤0.01%	4718
2022 Q4	–	Sell	-50,396	Closed	-$558K	–	7005
2022 Q3	$558K	Buy	+50,396	New	+$480K	﹤0.01%	4872
2021 Q2	–	Sell	-12,090	Closed	-$454K	–	6997
2021 Q1	$454K	Sell	12,090 -61,287	-84%	-$2.56M	﹤0.01%	4898
2020 Q4	$2.44M	Buy	+73,377	New	+$2.97M	﹤0.01%	3086